These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26039057)

  • 1. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
    Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
    PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
    Irwin RW; Brinton RD
    Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
    Hernandez GD; Solinsky CM; Mack WJ; Kono N; Rodgers KE; Wu CY; Mollo AR; Lopez CM; Pawluczyk S; Bauer G; Matthews D; Shi Y; Law M; Rogawski MA; Schneider LS; Brinton RD
    Alzheimers Dement (N Y); 2020; 6(1):e12107. PubMed ID: 33344752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.
    Chen S; Wang T; Yao J; Brinton RD
    Neurotherapeutics; 2020 Oct; 17(4):1813-1824. PubMed ID: 32632771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
    Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery.
    Zolkowska D; Wu CY; Rogawski MA
    Neurotherapeutics; 2021 Jan; 18(1):544-555. PubMed ID: 33405197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
    Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
    Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
    Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
    PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs.
    Vuu I; Patterson EE; Wu CY; Zolkowska D; Leppik IE; Rogawski MA; Worrell GA; Kremen V; Cloyd JC; Coles LD
    J Pharmacol Exp Ther; 2022 Feb; 380(2):104-113. PubMed ID: 34862270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
    Bengtsson SK; Johansson M; Bäckström T; Wang M
    J Alzheimers Dis; 2012; 31(1):71-84. PubMed ID: 22495347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus.
    Zolkowska D; Wu CY; Rogawski MA
    Epilepsia; 2018 Oct; 59 Suppl 2(Suppl 2):220-227. PubMed ID: 29453777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
    Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
    Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat.
    Zhu D; Wang MD; Bäckström T; Wahlström G
    Br J Anaesth; 2001 Mar; 86(3):403-12. PubMed ID: 11573532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
    Rockenstein E; Ubhi K; Doppler E; Novak P; Moessler H; Li B; Blanchard J; Grundke-Iqbal I; Iqbal K; Mante M; Adame A; Crews L; Masliah E
    J Alzheimers Dis; 2011; 27(4):743-52. PubMed ID: 21860085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice.
    Finn DA; Sinnott RS; Ford MM; Long SL; Tanchuck MA; Phillips TJ
    Neuroscience; 2004; 123(4):813-9. PubMed ID: 14751275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
    Wang T; Yao J; Chen S; Mao Z; Brinton RD
    Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
    Sun C; Ou X; Farley JM; Stockmeier C; Bigler S; Brinton RD; Wang JM
    Curr Alzheimer Res; 2012 May; 9(4):473-80. PubMed ID: 22272610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.